Home » Topics » BioWorld Science

BioWorld Science
RSS

New KDM1A inhibitors developed by Constellation Pharmaceuticals

May 15, 2018

Pfenex reports topline results from study of PF-708 in osteoporosis

May 15, 2018

Interpace to launch new thyroid test ThyGeNEXT

May 15, 2018

Chinese researchers divulge Trk inhibitors

May 15, 2018

Nimbus Lakshmi patents TYK2 inhibitors

May 15, 2018

NanoViricides confirms progress in HerpeCide program

May 15, 2018

FDA approves subcutaneous Actemra for active polyarticular juvenile idiopathic arthritis

May 15, 2018

Zymeworks and Daiichi Sankyo expand immuno-oncology collaboration

May 15, 2018

Medisix Therapeutics closes series A financing

May 15, 2018

Researchers develop PXDN-mutant microphthalmia and dysgenesis murine model

May 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...